• 1
    J Goulis, G Leandro, AK Burroughs. Randomised controlled trials of ursodeoxycholic acid therapy for primary biliary cirrhosis. Lancet 1999; 354:10531060.
  • 2
    Ursodeoxycholic acid for primary biliary cirrhosis. Drug Ther Bull 1999; 37:3032.
  • 3
    C Gluud, E Christensen. Ursodeoxycholic acid (UDCA) in primary biliary cirrhosis (PBC)—a Cochrane Hepato-Biliary systematic analysis [Abstract] J Hepatol 1999; 30:83A.
  • 4
    RE Poupon, B Balkau, E Eschwege, Poupon R and the UDCA-PBC Study Group. A multi-center controlled trial of ursodiol for the treatment of primary biliary cirrhosis. N Engl J Med 1991; 324:15481554.
  • 5
    RE Poupon, KD Lindor, K Cauch-Dudek, RE Dickson, R Poupon, EJ Heathcote. Combined analysis of randomised controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997; 113:884890.
  • 6
    HJ vanHoogstraten, BE Hansen, HR van Buuren, FJ ten Kate, GP van Berge-Henegouwen, SW Schalm. Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. Dutch Multi-centre PBC Study Group. J Hepatol 1999; 31:256262.
  • 7
    P Angulo, KD Lidon, TM Therneau, RA Jorgensen, M Malinchoc, PS Kamath, ER Dickson. Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid. Liver 1999; 19:115121.
  • 8
    U Leuschner, M Leuschner, J Sieratzki, W Kurtz, K Hubner. Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-up. A pilot study. Dig Dis Sci 1985; 30:642649.
  • 9
    R Poupon, Y Cretien, RE Poupon, F Ballet, Y Calmus, F Darnis. Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Lancet I: 1987;834836.
  • 10
    U Beuers, J Boyer, G Paumgartner. Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications. Hepatology 1998; 28:14491553.